I'd say, it depends on what you mean by "gone." I think biowin might disagree. He seems to be on top of current developments. The question is: are there any "developments" yet to be implemented which are helpful to our interests. I.E. has pursued these matters. After all, our investing during 2018 helped keep BioAmber afloat to contribute to a constructive "faith-in-the-technology" atmosphere, which served someone's interests other than our own during ongoing "liquidation" discussions, where "liquidation" appears to be a misleading term, legally.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.